Evidence map›Paper›PMID 19181835›Full record

ArticleApplied and environmental microbiology2009

Insights into structure-activity relationships in the C-terminal region of divercin V41, a class IIa bacteriocin with high-level antilisterial activity.

Jitka Rihakova, Vanessa W Petit, Katerina Demnerova, Hervé Prévost, Sylvie Rebuffat, Djamel Drider

Open access · greenAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Class IIa bacteriocins: diversity and new developments.International journal of molecular sciences · 2012
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Jitka RihakovaUMR INRA SECALIM 1014 ENITIAA-ENVN, Rue de la Géraudière, BP 82225, 44322 Nantes Cedex 3, France.
Vanessa W Petit
Katerina Demnerova
Hervé Prévost
Sylvie Rebuffat
Djamel Drider
University of Chemistry and Technology, Prague · CZCentre National de la Recherche Scientifique · FRInstitut National Polytechnique de Toulouse · FRMuséum national d'Histoire naturelle · FRSécurité des Aliments et Microbiologie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Divercin V41 (DvnV41) is a class IIa bacteriocin with potent antilisterial activity isolated from Carnobacterium divergens V41. Previously, we expressed from a synthetic gene, in Escherichia coli Origami, a recombinant DvnV41 designated DvnRV41, which possesses four additional amino acids (AMDP) in the N-terminal region that result from enzymatic cleavage and retains the initial DvnV41 activity. To unravel the relationship between the structure of DvnRV41 and its particularly elevated activity, we produced by site-directed mutagenesis eight variants in which a single amino acid replacement was specifically introduced into the sequence. The point mutations were designed to change either conserved residues in class IIa bacteriocins or residues specific to DvnV41 located mainly in the C-terminal region. The fusion proteins were purified from the cytosoluble fractions by immobilized affinity chromatography. DvnRV41 and its variants were released from the fusion proteins by enzymatic cleavage, using enterokinase. The purity of DvnRV41 and of the variants was checked by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, high-performance liquid chromatography, and mass spectrometry. The antibacterial activity of DvnRV41 and its variants was assessed using different indicator strains, including Listeria monocytogenes EGDe and Enterococcus faecalis JH2-2. The activity of all of the variants appeared to be less than the activity of DvnRV41. The decrease in activity did not appear to be related to a global conformational change, as determined by circular dichroism. Overall, the variants of DvnRV41 produced in the present study provide interesting insights into structure-activity relationships of class IIa bacteriocins.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionAnti-Bacterial AgentsBacteriocinsChromatography, AffinityCircular DichroismEnterococcus faecalisEscherichia coliListeria monocytogenesMicrobial Sensitivity TestsMolecular Sequence DataMutagenesis, Site-DirectedMutation, MissenseProtein ConformationStructure-Activity RelationshipAnti-Bacterial AgentsBacteriocinsdivercin V41

Identifiers

PMID19181835
PMCPMC2663188
OpenAlexW2035699802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.